APA

Armand P., Nagler A., Weller E. A., Devine S. M., Avigan D. E., Chen Y., Kaminski M. S., Holland H. K., Winter J. N., Mason J. R., Fay J. W., Rizzieri D. A., Hosing C. M., Ball E. D., Uberti J. P., Lazarus H. M., Mapara M. Y., Gregory S. A., Timmerman J. M., Andorsky D., Or R., Waller E. K., Rotem-Yehudar R. & Gordon L. I. (20140123). Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Armand Philippe, Nagler Arnon, Weller Edie A, Devine Steven M, Avigan David E, Chen Yi-Bin, Kaminski Mark S, Holland H Kent, Winter Jane N, Mason James R, Fay Joseph W, Rizzieri David A, Hosing Chitra M, Ball Edward D, Uberti Joseph P, Lazarus Hillard M, Mapara Markus Y, Gregory Stephanie A, Timmerman John M, Andorsky David, Or Reuven, Waller Edmund K, Rotem-Yehudar Rinat and Gordon Leo I. 20140123. Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Armand P., Nagler A., Weller E. A., Devine S. M., Avigan D. E., Chen Y., Kaminski M. S., Holland H. K., Winter J. N., Mason J. R., Fay J. W., Rizzieri D. A., Hosing C. M., Ball E. D., Uberti J. P., Lazarus H. M., Mapara M. Y., Gregory S. A., Timmerman J. M., Andorsky D., Or R., Waller E. K., Rotem-Yehudar R. and Gordon L. I. (20140123). Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Armand Philippe, Nagler Arnon, Weller Edie A, Devine Steven M, Avigan David E, Chen Yi-Bin, Kaminski Mark S, Holland H Kent, Winter Jane N, Mason James R, Fay Joseph W, Rizzieri David A, Hosing Chitra M, Ball Edward D, Uberti Joseph P, Lazarus Hillard M, Mapara Markus Y, Gregory Stephanie A, Timmerman John M, Andorsky David, Or Reuven, Waller Edmund K, Rotem-Yehudar Rinat and Gordon Leo I. Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20140123.